Serum amylase as a measure of salivary gland radiation damage. Hyperamylasaemia following fractionated exposure to 4 MV X rays delivered in high pressure oxygen, and effects of certain steroids on this response.
D000681:Amylases / Q000097:blood*; D001219:Aspartate Aminotransferases / Q000097:blood; D006801:Humans; D006931:Hyperbaric Oxygenation; D008525:Medroxyprogesterone / Q000627:therapeutic use; D009062:Mouth Neoplasms / Q000532:radiotherapy; D010306:Parotid Gland / Q000473:pathology; D010539:Permeability; D010610:Pharyngeal Neoplasms / Q000532:radiotherapy; D011239:Prednisolone / Q000627:therapeutic use*; D011343:Procaine / Q000494:pharmacology; D011374:Progesterone / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use*; D011832:Radiation Injuries; D011837:Radiation-Protective Agents; D011882:Radiotherapy, High-Energy / Q000009:adverse effects*; D012466:Salivary Gland Diseases / Q000097:blood* / Q000188:drug therapy; D012469:Salivary Glands / Q000528:radiation effects; D013233:Stellate Ganglion / Q000187:drug effects
D011372:Progestins; D011837:Radiation-Protective Agents; D011374:Progesterone; D011343:Procaine; D011239:Prednisolone; D001219:Aspartate Aminotransferases; D000681:Amylases; D008525:Medroxyprogesterone